A detailed history of Kelly Financial Services LLC transactions in Dexcom Inc stock. As of the latest transaction made, Kelly Financial Services LLC holds 70 shares of DXCM stock, worth $4,825. This represents 0.0% of its overall portfolio holdings.

Number of Shares
70
Previous 186 62.37%
Holding current value
$4,825
Previous $25,000 72.0%
% of portfolio
0.0%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$110.31 - $140.45 $12,795 - $16,292
-116 Reduced 62.37%
70 $7,000
Q1 2024

Jul 17, 2024

BUY
$114.22 - $140.1 $20,102 - $24,657
176 Added 1760.0%
186 $25,000
Q4 2023

Jul 17, 2024

SELL
$75.49 - $124.16 $75 - $124
-1 Reduced 9.09%
10 $1.24 Million
Q3 2023

Jul 17, 2024

BUY
$86.06 - $137.93 $946 - $1,517
11 New
11 $1.03 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $26.6B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Kelly Financial Services LLC Portfolio

Follow Kelly Financial Services LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kelly Financial Services LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kelly Financial Services LLC with notifications on news.